Halozyme makes 2 billion euro buyout offer for drug developer Evotec November 14, 2024 Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends ...

Last October Novo Nordisk announced that it had shelved plans to bring the world’s first oral insulin to market . But the company has just presented early stage data showing the formulation to ...

This marks an interesting change in medical research, where the patients are direct suppliers of data, beyond the information drawn from their medical records. Researchers must combine both ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...